Agenus (AGEN) Presents New Phase 1b Clinical Data on BOT/BAL Combination for MSS mCRC
Agenus Inc. (NASDAQ:AGEN) is one of the most undervalued penny stocks to buy right now.
Agenus Inc (AGEN)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Siren L.L.C. Raymond Debbane | 1,064,250 | $3,554,595 | 0.1% | |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 688,203 | $2,298,597 | +369% | 0% |
| 3. | Renaissance Technologies Jim Simons | 285,646 | $954,058 | -48% | 0% |
| 4. | GLG Partners Noam Gottesman | 278,980 | $931,793 | +145% | 0% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 170,922 | $570,879 | +400% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.65 | 500,000 | $324,050.00 | 625,969 | 2024-02-15 | Filing | |
| $0.76 | 25,000 | $19,000.00 | 124,063 | 2023-11-15 | Filing | |
| $3.61 | 40,388 | $145,853.18 | 1,590,441 | 2017-10-30 | Filing | |
| $3.51 | 59,612 | $209,261.96 | 1,550,053 | 2017-10-27 | Filing | |
| $3.29 | 29,456 | $97,054.57 | 1,418,477 | 2017-04-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.06 | 38,679 | $118,346.14 | 61,321 | 2022-01-06 | Filing | |
| $6.50 | 82,107 | $533,695.50 | 770,773 | 2021-09-13 | Filing | |
| $6.50 | 11,120 | $72,280.00 | 93,056 | 2021-09-10 | Filing | |
| $3.66 | 141,920 | $518,831.14 | 16,972,968 | 2020-06-17 | Filing | |
| $3.66 | 72,080 | $264,007.42 | 17,114,888 | 2020-06-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,440,232 | $4,810,375 | 0% | |
| 2. | 1,195,109 | $3,991,664 | 0% | |
| 3. | 545,662 | $1,822,511 | 0% | |
| 4. | 348,395 | $1,164,522 | 0% | |
| 5. | 295,821 | $988,042 | 0% |
News See All
11 Most Undervalued Penny Stocks to Buy Right Now
Earlier on January 27, Matt Stucky from Northwestern Mutual joined CNBC's 'Closing Bell Overtime' to discuss a shifting market landscape where investor focus is broadening beyond mega-cap stocks.
Agenus Inc. (AGEN) Surges After Zydus Agreement, Analysts Upbeat on Stock
Agenus Inc. (NASDAQ:AGEN) is among the 10 Most Undervalued Stocks to Buy for Under $5.
10 Most Undervalued Stocks to Buy for Under $5
The rush to safety from investors was reflected in the broad market index dropping 1.13%.
Baird Lifts Agenus (AGEN) PT to $6, Maintains Neutral Rating
This adjustment reflects an updated financial model following Agenus's receipt of a $91 million upfront payment from its collaboration with Zydus.
H.C. Wainwright Upgrades Agenus (AGEN) Stock to Buy
This comes after the company entered into a strategic collaboration with Zydus Lifesciences, an Indian multinational pharmaceutical company.
Agenus Inc. (NASDAQ:AGEN) Q1 2025 Earnings Call Transcript
Operator: Good morning and welcome to Agenus Inc.’s First Quarter 2025 Earnings Conference Call. Currently, all participants are in a listen-only mode.
Agenus Inc. (NASDAQ:AGEN) Q4 2024 Earnings Call Transcript
Operator: Good morning and welcome to Agenus Inc.'s Fourth Quarter and Year-End 2024 Earnings Conference Call. Currently all participants are in a listen-only mode.
Agenus Inc. (NASDAQ:AGEN) Q3 2024 Earnings Call Transcript
Operator: Good morning and welcome to Agenus' Third Quarter 2024 Conference Call and Webcast. All participants will be in a listen-only mode, until the question-and-answer session.
Agenus Inc. (NASDAQ:AGEN) Q2 2024 Earnings Call Transcript
Operator: Good morning and welcome to Agenus Second Quarter 2024 Results Conference Call and Webcast. All participants will be in a listen-only mode until the question-and-answer session.
Hedge Fund Resource Center